Paper
6 December 2022 Doxorubicin loaded gold nanoparticle for chemo and photothermal combination therapy of melanoma cancer
Kui Fan
Author Affiliations +
Proceedings Volume 12458, International Conference on Biomedical and Intelligent Systems (IC-BIS 2022); 124580H (2022) https://doi.org/10.1117/12.2660545
Event: International Conference on Biomedical and Intelligent Systems, 2022, Chengdu, China
Abstract
Cancer is one of the leading causes of incurable death and remains a serious disease worldwide. Of all types of skin cancer, melanoma is the most aggressive malignancy. Adriamycin is one of the most commonly used and important antibiotics among anti-cancer drugs in recent years and has a significant killing effect on melanoma cells when chemotherapy is administered using adriamycin. In PTT treatment, gold nanoparticles are used as photosensitizers with the property of warming up under 808 nm near infrared light to achieve melanoma inhibition. However, neither chemotherapy nor PTT alone is a good solution to this challenge and may result in a range of complications. We have therefore taken the approach of chemically combining adriamycin with gold nanoparticles to form a new nano-drug for treatment to compensate for its shortcomings when acting singly.
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Kui Fan "Doxorubicin loaded gold nanoparticle for chemo and photothermal combination therapy of melanoma cancer", Proc. SPIE 12458, International Conference on Biomedical and Intelligent Systems (IC-BIS 2022), 124580H (6 December 2022); https://doi.org/10.1117/12.2660545
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Gold

Nanoparticles

Melanoma

In vitro testing

Cancer

Particles

Near infrared

Back to Top